Brandon Smith
Direttore operativo presso PROTHENA CORPORATION PLC
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Brandon Smith
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROTHENA CORPORATION PLC | Direttore operativo | 29/09/2021 | - |
| Corporate Officer/Principal | 03/03/2020 | 29/09/2021 |
Storia della carriera di Brandon Smith
Precedenti posizioni note di Brandon Smith
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Direttore operativo | 01/01/2017 | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/06/2012 | 01/01/2017 |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2012 | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2005 | 01/01/2012 |
Formazione di Brandon Smith
| University of Michigan | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Irlanda | 2 |
| 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PROTHENA CORPORATION PLC | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Brandon Smith
- Esperienza
